These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19775319)

  • 1. Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels.
    Bargnoux AS; Dupuy AM; Garrigue V; Jaussent I; Gahide G; Badiou S; Szwarc I; Deleuze S; Vernhet H; Cristol JP; Mourad G
    Am J Transplant; 2009 Nov; 9(11):2571-9. PubMed ID: 19775319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients.
    Morena M; Dupuy AM; Jaussent I; Vernhet H; Gahide G; Klouche K; Bargnoux AS; Delcourt C; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2009 Nov; 24(11):3389-97. PubMed ID: 19574342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients.
    Kurnatowska I; Grzelak P; Kaczmarska M; Stefańczyk L; Nowicki M
    Nephron Clin Pract; 2011; 117(4):c297-304. PubMed ID: 20861651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers.
    Anand DV; Lim E; Darko D; Bassett P; Hopkins D; Lipkin D; Corder R; Lahiri A
    J Am Coll Cardiol; 2007 Dec; 50(23):2218-25. PubMed ID: 18061069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients.
    Morena M; Jaussent I; Halkovich A; Dupuy AM; Bargnoux AS; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
    PLoS One; 2012; 7(5):e36175. PubMed ID: 22567137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.
    Morena M; Jaussent I; Dupuy AM; Bargnoux AS; Kuster N; Chenine L; Leray-Moragues H; Klouche K; Vernhet H; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2015 Aug; 30(8):1345-56. PubMed ID: 25854266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
    Ahmed S; Sobh R
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
    J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between circulating serum osteoprotegerin and total receptor activator of nuclear κ-B ligand levels, triglycerides, and coronary calcification in postmenopausal women.
    Poornima IG; Mackey RH; Buhari AM; Cauley JA; Matthews KA; Kuller LH
    Menopause; 2014 Jul; 21(7):702-10. PubMed ID: 24473535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors associated with coronary artery calcification should be examined before kidney transplantation.
    Simic-Ogrizovic S; Bogavac-Stanojevic N; Vuckovic M; Dopsaj V; Giga V; Kravljaca M; Stosovic M; Lezaic V
    Tohoku J Exp Med; 2012 Feb; 226(2):137-44. PubMed ID: 22293651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT-Detected Growth of Coronary Artery Calcification in Asymptomatic Middle-Aged Subjects and Association With 15 Biomarkers.
    Diederichsen SZ; Grønhøj MH; Mickley H; Gerke O; Steffensen FH; Lambrechtsen J; Rønnow Sand NP; Rasmussen LM; Olsen MH; Diederichsen A
    JACC Cardiovasc Imaging; 2017 Aug; 10(8):858-866. PubMed ID: 28797406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease.
    Mesquita M; Demulder A; Damry N; Mélot C; Wittersheim E; Willems D; Dratwa M; Bergmann P
    Clin Chem Lab Med; 2009; 47(3):339-46. PubMed ID: 19676147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does osteoprotegerin or receptor activator of nuclear factor-kappaB ligand mediate the association between bone and coronary artery calcification?
    Bakhireva LN; Laughlin GA; Bettencourt R; Barrett-Connor E
    J Clin Endocrinol Metab; 2008 May; 93(5):2009-12. PubMed ID: 18319315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoprotegerin, but not osteopontin, as a potential predictor of vascular calcification in normotensive subjects.
    Stępień E; Fedak D; Klimeczek P; Wilkosz T; Banyś RP; Starzyk K; Bazanek M; Pasowicz M
    Hypertens Res; 2012 May; 35(5):531-8. PubMed ID: 22278625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.
    Malluche HH; Blomquist G; Monier-Faugere MC; Cantor TL; Davenport DL
    J Am Soc Nephrol; 2015 Oct; 26(10):2534-44. PubMed ID: 25838468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of coronary artery calcification in renal transplant recipients.
    Seyahi N; Cebi D; Altiparmak MR; Akman C; Ataman R; Pekmezci S; Serdengecti K
    Nephrol Dial Transplant; 2012 May; 27(5):2101-7. PubMed ID: 21965591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of coronary artery calcification in patients with chronic kidney disease Stages 3 and 4, with and without diabetes.
    Stavroulopoulos A; Porter CJ; Pointon K; Monaghan JM; Roe SD; Cassidy MJ
    Nephrol Dial Transplant; 2011 Aug; 26(8):2582-9. PubMed ID: 21224493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).
    Abedin M; Omland T; Ueland T; Khera A; Aukrust P; Murphy SA; Jain T; Gruntmanis U; McGuire DK; de Lemos JA
    Am J Cardiol; 2007 Feb; 99(4):513-8. PubMed ID: 17293196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of coronary artery calcification and thoracic aorta calcification in kidney transplant recipients.
    Maréchal C; Coche E; Goffin E; Dragean A; Schlieper G; Nguyen P; Floege J; Kanaan N; Devuyst O; Jadoul M
    Am J Kidney Dis; 2012 Feb; 59(2):258-69. PubMed ID: 21944666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of osteoprotegerin are associated with coronary artery calcification in patients suspected of a chronic coronary syndrome.
    Dekker M; Waissi F; Silvis MJM; Bennekom JV; Schoneveld AH; de Winter RJ; Isgum I; Lessmann N; Velthuis BK; Pasterkamp G; Mosterd A; Timmers L; de Kleijn DPV
    Sci Rep; 2021 Sep; 11(1):18946. PubMed ID: 34556709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.